Evidence map›Paper›PMID 32733066›Full record

Trial reportScientific reports2020

Precision-based exercise as a new therapeutic option for children and adolescents with haematological malignancies.

Francesca Lanfranconi, W Zardo, T Moriggi, E Villa, G Radaelli, S Radaelli, F Paoletti, E Bottes, T Miraglia, L Pollastri and 5 more

Abstract readClinical Trial
In one paragraph

Trial report in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Francesca LanfranconiPaediatric Haematology-Oncology Unit, Department of Paediatrics, University of Milano-Bicocca, MBBM Foundation/ASST Monza, Maria Letizia Verga Center-Via Cadore, 20900, Monza, Italy. francesca.lanfranconi@unimib.it.
W ZardoPaediatric Haematology-Oncology Unit, Department of Paediatrics, University of Milano-Bicocca, MBBM Foundation/ASST Monza, Maria Letizia Verga Center-Via Cadore, 20900, Monza, Italy.
T MoriggiPaediatric Haematology-Oncology Unit, Department of Paediatrics, University of Milano-Bicocca, MBBM Foundation/ASST Monza, Maria Letizia Verga Center-Via Cadore, 20900, Monza, Italy.
E VillaPaediatric Haematology-Oncology Unit, Department of Paediatrics, University of Milano-Bicocca, MBBM Foundation/ASST Monza, Maria Letizia Verga Center-Via Cadore, 20900, Monza, Italy.
G RadaelliPaediatric Haematology-Oncology Unit, Department of Paediatrics, University of Milano-Bicocca, MBBM Foundation/ASST Monza, Maria Letizia Verga Center-Via Cadore, 20900, Monza, Italy.
S RadaelliPaediatric Haematology-Oncology Unit, Department of Paediatrics, University of Milano-Bicocca, MBBM Foundation/ASST Monza, Maria Letizia Verga Center-Via Cadore, 20900, Monza, Italy.
F PaolettiPaediatric Haematology-Oncology Unit, Department of Paediatrics, University of Milano-Bicocca, MBBM Foundation/ASST Monza, Maria Letizia Verga Center-Via Cadore, 20900, Monza, Italy.
E BottesPaediatric Haematology-Oncology Unit, Department of Paediatrics, University of Milano-Bicocca, MBBM Foundation/ASST Monza, Maria Letizia Verga Center-Via Cadore, 20900, Monza, Italy.
T MiragliaPaediatric Haematology-Oncology Unit, Department of Paediatrics, University of Milano-Bicocca, MBBM Foundation/ASST Monza, Maria Letizia Verga Center-Via Cadore, 20900, Monza, Italy.
L PollastriPaediatric Haematology-Oncology Unit, Department of Paediatrics, University of Milano-Bicocca, MBBM Foundation/ASST Monza, Maria Letizia Verga Center-Via Cadore, 20900, Monza, Italy.
P VagoCattolica University - Department of Pedagogy, Milan, Italy.
F NichelliPaediatric Haematology-Oncology Unit, Department of Paediatrics, University of Milano-Bicocca, MBBM Foundation/ASST Monza, Maria Letizia Verga Center-Via Cadore, 20900, Monza, Italy.
M JankovicPaediatric Haematology-Oncology Unit, Department of Paediatrics, University of Milano-Bicocca, MBBM Foundation/ASST Monza, Maria Letizia Verga Center-Via Cadore, 20900, Monza, Italy.
A BiondiPaediatric Haematology-Oncology Unit, Department of Paediatrics, University of Milano-Bicocca, MBBM Foundation/ASST Monza, Maria Letizia Verga Center-Via Cadore, 20900, Monza, Italy.
A BalduzziPaediatric Haematology-Oncology Unit, Department of Paediatrics, University of Milano-Bicocca, MBBM Foundation/ASST Monza, Maria Letizia Verga Center-Via Cadore, 20900, Monza, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Children and adolescents with haematological malignancies (PedHM) are characterized by a severe loss of exercise ability during cancer treatment, lasting throughout their lives once healed and impacting their social inclusion prospects. The investigation of the effect of a precision-based exercise program on the connections between systems of the body in PedHM patients is the new frontier in clinical exercise physiology. This study is aimed at evaluating the effects of 11 weeks (3 times weekly) of combined training (cardiorespiratory, resistance, balance and flexibility) on the exercise intolerance in PedHM patients. Two-hundred twenty-six PedHM patients were recruited (47% F). High or medium frequency participation (HAd and MAd) was considered when a participant joined; > 65% or between 30% and < 64% of training sessions, respectively. The "up and down stairs'' test (TUDS), "6 min walking" test (6MWT), the "5 Repetition Maximum strength" leg extension and arm lateral raise test (5RM-LE and 5RM-ALR), flexibility (stand and reach), and balance (stabilometry), were performed and evaluated before and after training. The TUDS, the 5RM-LE and 5RM-ALR, and the flexibility exercises showed an increase in HAd and MAd groups (P < 0.05), while the 6MWT and balance tests showed improvement only in HAd group (P < 0.0001). These results support the ever-growing theory that, in the case of the treatment of PedHM, 'exercise is medicine' and it has the potential to increase the patient's chances of social inclusion.

Indexed as

Exercise TherapyMuscle StrengthPhysical FitnessPostural BalanceAdolescentAdultChildChild, PreschoolFemaleHematologic NeoplasmsHumansMalePrecision Medicine

Identifiers

PMID32733066
PMCPMC7393502

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.